Correlation between aryl hydrocarbon receptor and IL-17+ and Foxp3+ T-cell infiltration in bladder cancer

Bladder cancer (BC) is one of the most prevalent cancers around the world and, if not treated well, has high morbidity and mortality. Many studies have indicated that there may be various roles for the aryl hydrocarbon receptor (AHR) in the immune system. The aim of this study was to determine the frequency of Foxp3⁺ regulatory T (Treg) and T helper 17 cells (Th17) in BC tissue in comparison with controls and determine the relationship between AHR, Foxp3⁺ Treg and Th17 cells in BC. A total of 40 patients with BC were enrolled in this study. The control group was selected from non-tumoural parts of bladder tissues from the patients who have undergone cystoscopy. The percentage of regulatory T cells (Foxp3⁺/CD4⁺) and Th17 (IL-17⁺/CD4⁺), as well as AHR⁺ cells in BC tissues and controls, were determined by immunohistochemistry. The results of this study showed that the number of Foxp3⁺ Treg and Th17 is significantly higher in bladder tumour tissues in comparison with non-tumoural tissues. Also, the percentage of AHR⁺ lymphocytes and AHR⁺ cells was increased significantly in bladder tumour tissues rather than non-tumoural tissues. This study also found a relation between AHR and Foxp3⁺/CD4⁺ T lymphocytes ratio cells in BC. The percentage of Foxp3⁺ Tregs and AHR⁺ cells were significantly correlated with the grade and stage of BC. An increase in the percentage of Foxp3⁺ Treg and Th17 cells may play an important role in tumour immunity; and determining the relationship between AHR and differentiation of Th17/Foxp3⁺Treg in BC can lead to a potential cancer therapeutic possibility.